Andreas H. Marx

Merck KGaA, Frankfurter Str. 250
Darmstadt, HE 64293, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 164 publications

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Expression of Thymidylate Synthase in Cancer: A Tissue Microarray Study Involving 17,371 Cancers from 136 Tumor Entities.

Journal: Biomedicines

Published: February 17, 2026

Identification, structural elucidation and nonclinical characterisation of oxMET1: a further major metabolite of xevinapant?

Identification, structural elucidation and nonclinical characterisation of oxMET1: a further major metabolite of xevinapant?

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: February 16, 2026

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

Journal: Diagnostics (Basel, Switzerland)

Published: February 16, 2026

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Journal: Frontiers in oncology

Published: February 12, 2026

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Journal: Molecular medicine (Cambridge, Mass.)

Published: December 16, 2025

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types.

Journal: Virchows Archiv : an international journal of pathology

Published: November 04, 2025

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes.

Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes.

Journal: Cancers

Published: October 26, 2025

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

Journal: Genes, chromosomes & cancer

Published: August 28, 2025

PROTAC Enabling Formulation In Vivo: Implications of the Polymeric Carrier Eudragit E PO.

PROTAC Enabling Formulation In Vivo: Implications of the Polymeric Carrier Eudragit E PO.

Journal: Molecular pharmaceutics

Published: August 24, 2025

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.

Journal: Experimental and molecular pathology

Published: July 23, 2025

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Journal: Cancer medicine

Published: July 22, 2025

The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanisms.

The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanisms.

Journal: bioRxiv : the preprint server for biology

Published: July 09, 2025

Showing 1-12 of 164

Last Updated: 09/26/2026